The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

Tumors can destroy the blood vessels of muscles even when the muscles are nowhere close to the tumor. That is the key finding ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts.

When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

The San Diego-based firm said that it is transitioning beyond laboratory-developed tests and expanding access to its tests for the detection of early-stage cancers.

Lack of early detection: One risk factor is also the fact that there are no early detection methods for pancreatic cancer, unlike breast or colon cancer. Future research will focus on blood tests ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Researchers from the University of British Columbia (UBC) have uncovered a direct connection between high insulin ...